Skip to main content

Medtronic plc

corporate_fare Company Profile

Medtronic plc

MDT·NYSE·Life Sciences·CIK 0001613103

Medtronic plc, headquartered in Galway, Ireland, is a global healthcare technology company. Founded in 1949, Medtronic serves healthcare systems, physicians, clinicians, and patients in over 150 countries worldwide. The company operates with a mission established in 1960: "to contribute to human welfare by the application of biomedical engineering in the research, design, manufacture, and sale of products to alleviate pain, restore health, and extend life." Medtronic's business strategy focuses on three key areas. First, it aims to accelerate innovation-driven growth by bringing inventive and disruptive technology to healthcare opportunities, leveraging recent product launches and a robust pipeline to meet patient needs and increase product adoption globally. Second, the company strives to deliver superior outcomes and better experiences for patients and providers by understanding customer challenges and creating agile partnerships to deploy therapies. Third, Medtronic seeks to turn data, AI, and automation into action, utilizing new technology, AI, and data analytics to tailor therapies in real-time, facilitate remote monitoring and care delivery, and establish new standards of care. The company has three reportable segments that primarily develop, manufacture, distribute, and sell device-based medical therapies and services: the Cardiovascular Portfolio, the Neuroscience Portfolio, and the Medical Surgical Portfolio.

Medtronic plc (NYSE:MDT) is a publicly traded company in the Life Sciences sector. Wiseek monitors MDT SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Medtronic's OmniaSecure Lead First to Win FDA Approval for Advanced Cardiac Pacing
  • Medtronic to Acquire Scientia Vascular, Expanding Medical Device Portfolio
  • Medtronic's MiniMed Unit Shares Drop 4.8% in Nasdaq Debut, Valued at $5.3 Billion
  • Medtronic's MiniMed Subsidiary Announces IPO Pricing
  • Medtronic Reports Q3 GAAP EPS Decline Amid Restructuring & Faces $1.1B+ Antitrust Verdict

Financial Snapshot

Fiscal year ended April 24, 2026
Revenue
$36.36B
Net Income
$4.8B
Diluted EPS
$3.73
Op. Cash Flow
$7.33B
Free Cash Flow
$5.43B
Gross Profit
$23.64B
Operating Income
$6.47B
Cash & Equivalents
$1.95B
Total Debt
$1.79B
Debt / Equity
0.04×
Net Margin
13.2%
Shares Outstanding
1.28B sh
Source: 10-K · filed 2026-06-18 · accession 0001628280-26-044354
$84.1 -0.12% today
52-week range · as of 2026-06-18 $73.31 – $106.33
Market cap
$107.81B
Volume
5.4M (0.6× avg)
3-mo avg 8.5M
Live data · 2026-07-28 04:44 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed MDT - Filings & News (Page 2)

MDT
Mar 23, 2026, 9:38 AM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $86.51
Real-time Price: $84.10 info
Change: -$2.41 (-3%) info
Market Cap: $107.805B info
MDT
Mar 10, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $91.91
Real-time Price: $84.10 info
Change: -$7.81 (-8%) info
Market Cap: $107.805B info
MDT
Mar 06, 2026, 12:11 PM EST
Source: Reuters
Importance Score:
8
Price at Filing: $90.78
Real-time Price: $84.10 info
Change: -$6.68 (-7%) info
Market Cap: $107.805B info
MDT
Mar 05, 2026, 7:40 PM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $93.03
Real-time Price: $84.10 info
Change: -$8.93 (-10%) info
Market Cap: $107.805B info
MDT
Feb 24, 2026, 4:18 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $96.75
Real-time Price: $84.10 info
Change: -$12.65 (-13%) info
Market Cap: $107.805B info
MDT
Feb 17, 2026, 6:48 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $102.22
Real-time Price: $84.10 info
Change: -$18.12 (-18%) info
Market Cap: $107.805B info